Ginkgo Bioworks Stock

ginkgobioworks.comBioTechFounded: 2008Funding to Date: $785.53MM

Ginkgo Bioworks is the developer of a cell programming platform enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Ginkgo Bioworks, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Jason Kelly
Co-Founder, Chief Executive Officer & Board Member
Austin Che
Co-Founder
Barry Canton
Co-Founder
Reshma Shetty
Co-Founder, President & Board Member
Tom Knight
Co-Founder
Ena Cratsenburg
Chief Business Officer
Peter Boynton
Chief Commercial Officer

Board Members

Christian Henry
Marjin Dekkers

Other companies like Ginkgo Bioworks in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$289.42MM

News

Ginkgo Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Ginkgo’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the company. It’s also one of the biggest SPAC deals done…
The companies’ goal is to make the production process more efficient.